Both ARBs and gene silencing of AT1R reduce p-ERK levels and, consequently, proliferation in gastric [53], ovarian [49] and pancreatic [54] cancer cells, with these effects replicated in xenograft models [49, 54]. The gene discussed is AGTR1; the disease is cancer.